Status:
RECRUITING
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sarcoma
Eligibility:
All Genders
Brief Summary
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
Detailed Description
* To evaluate the incidence and prevalence and the impact of disease, treatment, sociodemographic and lifestyle contributors on adverse oncologic outcomes (lack of response, recurrence) and non- oncol...
Eligibility Criteria
Inclusion
- Patients at any age with a history of sarcoma, with or without evidence of a persistent disease
- • For pediatric patients
- Parent/primary caregiver of patient
- Sibling of patient aged 8 years or older
Exclusion
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT06482957
Start Date
April 1 2022
End Date
April 1 2029
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States, 37203